Abstract
Mannheimia haemolytica is the principal microorganism responsible for bovine pneumonic pasteurellosis, or shipping fever. We have previously expressed a fragment of leukotoxin, a major virulent factor of M. haemolytica A1, as a fusion protein with green fluorescent protein (GFP) in transgenic white clover and demonstrated that this antigen was immunogenic and elicited toxin neutralizing antibodies in rabbits. These previous results showed that using plants to produce M. haemolytica antigen for use as a vaccine against this disease is a viable strategy. In this present study, we examined the stability of the truncated leukotoxin GFP-fusion protein (Lkt50-GFP) in field-grown transgenic white clover. Transgenic clover expressing Lkt50-GFP was clonally propagated and a confined field trial was established. Western immunoblotting showed that the level of Lkt50-GFP expression in field plants was the same as in transgenic plants maintained under optimal conditions in the greenhouse. We also observed that after harvesting and oven drying at 50 °C, the antigen was still present in the dried clover after 1 year of storage at ambient temperature. As special post-harvest conditions (e.g., refrigeration) are not required, the use of transgenic plants to deliver an oral vaccine against shipping fever appears to be economically feasible.
Article PDF
Similar content being viewed by others
References
Confer A.W., Clinkenbeard K.D., Gatewood D.M., Driskel B.A. and Montelongo M. 1997. Serum antibody responses of cattle vaccinated with partially purified native Pasteurella haemolytica leukotoxin. Vaccine 15: 1423–1429.
Cruz W.T., Young R., Chang Y.F. and Struck D.K. 1990. Deletion analysis resolves cell-binding and lytic domains of the Pasteurella leukotoxin. Mol. Microbiol. 4: 1933–1939.
Giddings G., Allison G., Brooks D. and Carter A. 2000. Transgenic plants as factories for biopharmaceuticals. Nat. Biotechnol. 18: 1151–1155.
Haseloff J. and Siemering K.R. 1998. The uses of green fluorescent protein in plants. In: Chalfie M. and Kain S. (eds), Green Fluorescent Protein: Properties, Applications, and Protocols. Wiley-Liss, Inc., New York, pp. 191–220.
Haseloff J., Siemering K.R., Prasher D.C. and Hodge S. 1997. Removal of a cryptic intron and subcellular localization of green fluorescent protein are required to mark transgenic Arabidopsis plants brightly. Proc. Natl. Acad. Sci. USA 94: 2122–2127.
Highlander S.K. 2001. Molecular genetic analysis of virulence in Mannhiemia (Pasteurella) haemolytica. Front. Biosci. 6: d1128–d1150.
Lee R.W.H., Strommer J., Hodgins D., Shewen P.E., Niu Y. and Lo R.Y.C. 2001. Towards development of an edible vaccine against bovine pneumonic pasteurellosis using transgenic white clover expressing a Mannheimia haemolytica A1 leukotoxin 50 fusion protein. Infect. Immun. 69: 5786–5793.
Lo R.Y.C. 2001. Genetic analysis of virulence factors of Mannheimia (Pasteurella) haemolytica A1. Vet. Microbiol. 83: 23–35.
Lo R.Y.C., Watt M., Gyroffy S. and Mellors A. 1994. Preparation of recombinant glycoprotease of Pasteurella haemolytica A1 utilizing the Escherichia coli α-hemolysin secretion system. FEMS Microbiol. Lett. 116: 225–230.
Meins F. Jr and Kunz C. 1995. Gene silencing in transgenic plants: a heuristic autoregulation model. Curr. Top. Microbiol. Immunol. 197: 105–120.
Narayanan S.K., Nagaraja T.G., Chengappa M.M. and Stewart G.C. 2002. Leukotoxins of gram-negative bacteria. Vet. Microbiol. 84: 337–356.
Rajeev S., Kania S.A., Nair R.V., McPherson J.T., Moore R.N. and Bemis D.A. 2001. Bordetella bronchiseptica fimbrial proteinenhanced immunogenicity of a Mannheimia haemolytica leukotoxin fragment. Vaccine 19: 4842–4850.
Richter L. and Kipp P.B. 1999. Transgenic plants as edible vaccines. Curr. Top. Microbiol. Immunol. 240: 159–176.
Streatfield S.J., Mayor J.M., Barker D.K., Brooks C., Lamphear B.J., Woodard S.L. et al. 2002. Development of an edible subunit vaccine in corn against enterotoxigenic strains of Escherichia coli. In Vitro Cell Dev. Biol. - Plant 38: 11–17.
Walmsley A.M. and Arntzen C.J. 2000. Plants for delivery of edible vaccines. Curr. Opin. Biotechnol. 11: 126–129.
Wu L. and Barry M.A. 2000. Fusion protein vectors to increase protein production and evaluate the immunogenicity of genetic vaccines. Mol. Ther. 2: 288–297.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Lee, R.W., Pool, A.N., Ziauddin, A. et al. Edible vaccine development: stability of Mannheimia haemolytica A1 leukotoxin 50 during post-harvest processing and storage of field-grown transgenic white clover. Molecular Breeding 11, 259–266 (2003). https://doi.org/10.1023/A:1023431123595
Issue Date:
DOI: https://doi.org/10.1023/A:1023431123595